Selection criteria for early breast cancer patients in the DBCG proton trial – The randomised phase III trial strategy

Selection criteria for early breast cancer patients in the DBCG proton trial – The randomised phase III trial strategy

Background and purpose: Adjuvant radiotherapy of internal mammary nodes (IMN) improves survival in high-risk early breast cancer patients but inevitably leads to more dose to heart and lung. Target coverage is often compromised to meet heart/lung dose constraints. We estimate heart and lung dose whe...

Full description

Bibliographic Details
Main Authors: Line Bjerregaard Stick, Ebbe Laugaard Lorenzen, Esben Svitzer Yates, Carmel Anandadas, Karen Andersen, Cynthia Aristei, Orla Byrne, Sandra Hol, Ingelise Jensen, Anna M. Kirby, Youlia M. Kirova, Livia Marrazzo, Angela Matías-Pérez, Mette Marie Bruun Nielsen, Henrik Dahl Nissen, Sileida Oliveros, Karolien Verhoeven, Johan Vikström, Birgitte Vrou Offersen
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Patient selection
Breast cancer
Proton therapy
Heart and lung exposure
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630821000124

Internet

http://www.sciencedirect.com/science/article/pii/S2405630821000124

Similar Items